NEW YORK (AP) — Drug distributor McKesson Corp. pared its lobbying spending by 61 percent in the third quarter versus a year earlier, spending $110,000 as it discussed a contract with the Department of Veterans Affairs and a variety of legislation, according to a recent federal filing.
The San Francisco company previously said it spent more than $281,000 on lobbying in the third quarter of 2009. It has reduced its lobbying costs significantly in the first three quarters of 2010, and had spent $240,000 in the second quarter of this year.
Its lobbying interests included the prime pharmaceutical vendor contract for the Department of Veterans Affairs, as well as legislation affecting Social Security and the Food and Drug Administration, pharmaceutical marketing and tax and financial issues.
It lobbied Congress, the Department of Health and Human Services, the Centers for Medicare & Medicaid Services, and the FDA.
McKesson disclosed its latest lobbying spending in a form filed Oct. 20 with the House clerk's office.